×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
FSNUY – fresenius se s/adr (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
FSNUY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/26
01:41 pm
fsnuy
Fresenius SE & Co. KGaA 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
Low
Report
Fresenius SE & Co. KGaA 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
2/22
03:32 pm
fsnuy
Fresenius SE & Co. KGaA (OTCMKTS: FSNUY) had its "buy" rating re-affirmed by analysts at Deutsche Bank Aktiengesellschaft.
Low
Report
Fresenius SE & Co. KGaA (OTCMKTS: FSNUY) had its "buy" rating re-affirmed by analysts at Deutsche Bank Aktiengesellschaft.
2/13
12:14 pm
fsnuy
Angels for Change Launches Project GOLD [Yahoo! Finance]
Low
Report
Angels for Change Launches Project GOLD [Yahoo! Finance]
2/10
09:54 am
fsnuy
Fresenius Kabi Introduces Calcitonin Salmon Injection, USP Synthetic [Yahoo! Finance]
Low
Report
Fresenius Kabi Introduces Calcitonin Salmon Injection, USP Synthetic [Yahoo! Finance]
2/4
09:31 am
fsnuy
Angels for Change Announce 2024 Change Maker of the Year Award [Yahoo! Finance]
Low
Report
Angels for Change Announce 2024 Change Maker of the Year Award [Yahoo! Finance]
1/8
08:43 am
fsnuy
Fresenius Kabi Canada has received a Health Canada Notice of Compliance (NOC) for Otulfi™* an Ustekinumab Biosimilar [Globe and Mail, The (Toronto, Canada)]
Low
Report
Fresenius Kabi Canada has received a Health Canada Notice of Compliance (NOC) for Otulfi™* an Ustekinumab Biosimilar [Globe and Mail, The (Toronto, Canada)]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/24
FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "outperform" rating.
14.1%
4/7 FRESENIUS SE &/S (OTCMKTS: FSNUY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 2.8%
5/7 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 2.3%
4/23 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 1.2%
12/11 FRESENIUS SE &/S (OTCMKTS: FSNUY) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 1.1%
11/5 Things are getting nasty in the 7th Circuit’s big M&A shareholder class action case [Reuters] 0.9%
4/3 Italy looks to safeguard biomedical valley leading fight against COVID-19 [Reuters (UK)] 0.8%
11/6 Fresenius SE & Co. KGaA to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 13 November 2019 0.4%
4/7 FRESENIUS SE &/S (OTCMKTS: FSNUY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 2.8%
5/7 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 2.3%
4/23 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 1.2%
12/11 FRESENIUS SE &/S (OTCMKTS: FSNUY) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 1.1%
11/5 Things are getting nasty in the 7th Circuit’s big M&A shareholder class action case [Reuters] 0.9%
4/3 Italy looks to safeguard biomedical valley leading fight against COVID-19 [Reuters (UK)] 0.8%
11/6 Fresenius SE & Co. KGaA to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 13 November 2019 0.4%
TOP News Decliners
4/30
FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.
-2.6%
2/27 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -2.5%
4/23 FRESENIUS SE &/S (OTCMKTS: FSNUY) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. -2.1%
1/24 FRESENIUS SE &/S (OTCMKTS: FSNUY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -2.0%
3/9 FRESENIUS SE &/S (OTCMKTS: FSNUY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -1.9%
12/17 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -1.7%
6/5 New paper documents mootness fee phenomenon in M&A cases, proposes solution [Reuters] -1.2%
4/27 FRESENIUS SE &/S (OTCMKTS: FSNUY) had its "equal weight" rating re-affirmed by analysts at Barclays PLC. -0.6%
2/17 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -0.5%
4/3 Italy looks to safeguard biomedical valley leading fight against COVID-19 [Reuters] -0.3%
2/27 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -2.5%
4/23 FRESENIUS SE &/S (OTCMKTS: FSNUY) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. -2.1%
1/24 FRESENIUS SE &/S (OTCMKTS: FSNUY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -2.0%
3/9 FRESENIUS SE &/S (OTCMKTS: FSNUY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -1.9%
12/17 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -1.7%
6/5 New paper documents mootness fee phenomenon in M&A cases, proposes solution [Reuters] -1.2%
4/27 FRESENIUS SE &/S (OTCMKTS: FSNUY) had its "equal weight" rating re-affirmed by analysts at Barclays PLC. -0.6%
2/17 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -0.5%
4/3 Italy looks to safeguard biomedical valley leading fight against COVID-19 [Reuters] -0.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: